Using a computer-generated randomisation sequence , we assigned patients ( 1:1 ; stratified by geographical region and ECOG performance status , with a permuted block method ) to receive panitumumab ( 6 mg/kg once every 2 weeks ) or cetuximab ( initial dose 400 mg/m ( 2 ) ; 250 mg/m ( 2 ) once a week thereafter ) .